Bristol Myers Squibb Quotes

Giselle Chapman was hired by Bristol-Myers Squibb, one of the leading pharmaceutical companies at that time. She became their number one sales representative, and went on to form her own consulting company.

Along with support by pharmaceutical giants such as Janssen Therapeutics, Johnson & Johnson, Viiv, Pfizer, Abbott Laboratories, Bristol-Myers Squibb, and Boehringer Ingelheim Pharmaceuticals, major technology corporations including Google, Microsoft, Amazon, Intel, Dell, and IBM are also funding the transgender project. In February 2017, Apple, Microsoft, Google, IBM, Yelp, PayPal, and 53 other mostly tech corporations signed onto an amicus brief pushing the US Supreme Court to prohibit schools from keeping private facilities for students designated according to sex.

Looking at a few of the top players, the Pharmaceutical Research and Manufacturers of America, PhRMA, spent $27.6 million on lobbying in 2023 alone. Pharmaceutical Care Management Association, the big industry group for pharmaceutical and insurance middlemen called PBAs, laid out $15.4 million for lobbying during the same year. Pfizer, Amgen, Merck, Roche, Eli Lily, Bristol-Myers Squibb, and Gilead Sciences spent between $8.3 million and $14.3 million each lobbying to get what they want. Those are just a few. What is it these drug industry interests want? Many desires are on the table. It could be they want to increase the chances that the government will agree to pay lucrative prices for their star products through Medicare and Medicaid, insurance for the elderly and poor. It could be that the pharmaceutical companies are paying for access so that their lobbyists are invited to help write congressional bills to their benefit—and deep-six provisions that could hurt their bottom line.

Fauci waved through another DNA chain antiretroviral terminator drug to quick approval, allowing it to skip the double-blind placebo testing he had previously declared indispensable. NIH had developed and patented didanosine (ddI) before licensing it to Bristol Myers Squibb.125 Didanosine won FDA approval without even a pretense of a placebo-controlled study.